down arrow

Cheng Du Sheng Nuo Biotec Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000051M8
CNY
40.15
-0.1 (-0.25%)

Dec 19

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Cheng Du Sheng Nuo Biotec Co., Ltd.
Why is Cheng Du Sheng Nuo Biotec Co., Ltd. ?
1
  • PRE-TAX PROFIT(Q) At CNY 47.22 MM has Grown at 1,080.85%
  • NET PROFIT(Q) At CNY 41.86 MM has Grown at 687.51%
  • ROCE(HY) Highest at 12.5%
2
With ROE of 11.78%, it has a fair valuation with a 5.99 Price to Book Value
  • Over the past year, while the stock has generated a return of 103.00%, its profits have risen by 62.8%
3
Market Beating performance in long term as well as near term
  • Along with generating 103.00% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Cheng Du Sheng Nuo Biotec Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Cheng Du Sheng Nuo Biotec Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Cheng Du Sheng Nuo Biotec Co., Ltd.
103.0%
1.06
63.79%
China Shanghai Composite
15.44%
1.06
14.51%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.55%
EBIT Growth (5y)
107.84%
EBIT to Interest (avg)
6.55
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
0.32
Sales to Capital Employed (avg)
0.36
Tax Ratio
17.66%
Dividend Payout Ratio
22.40%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.26%
ROE (avg)
9.15%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
51
Industry P/E
Price to Book Value
5.99
EV to EBIT
42.06
EV to EBITDA
32.69
EV to Capital Employed
4.91
EV to Sales
10.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.68%
ROE (Latest)
11.78%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company
PRE-TAX PROFIT(Q)

At CNY 47.22 MM has Grown at 1,080.85%

NET PROFIT(Q)

At CNY 41.86 MM has Grown at 687.51%

ROCE(HY)

Highest at 12.5%

NET SALES(Q)

At CNY 151.07 MM has Grown at 61.35%

RAW MATERIAL COST(Y)

Fallen by -3.18% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.16%

OPERATING PROFIT MARGIN(Q)

Highest at 39.99 %

-13What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 83.12 MM

INTEREST(Q)

Highest at CNY 3.77 MM

Here's what is working for Cheng Du Sheng Nuo Biotec Co., Ltd.
Pre-Tax Profit
At CNY 47.22 MM has Grown at 1,080.85%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 41.86 MM has Grown at 687.51%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales
At CNY 151.07 MM has Grown at 61.35%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (CNY MM)

Operating Profit Margin
Highest at 39.99 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Debtors Turnover Ratio
Highest at 4.16%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -3.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cheng Du Sheng Nuo Biotec Co., Ltd.
Interest
At CNY 3.77 MM has Grown at 14.79%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 83.12 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
Highest at CNY 3.77 MM
in the last five periods and Increased by 14.79% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."